<DOC>
	<DOCNO>NCT01560403</DOCNO>
	<brief_summary>This study 1-year open label extension study collect long term efficacy safety data patient complete approximately 2 year dose Study CL0600-021 .</brief_summary>
	<brief_title>A One-Year , Open-Label Study With Teduglutide Subjects Who Completed Study CL0600-021</brief_title>
	<detailed_description>This study serve 1-year extension study US patient complete CL0600-021 study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<criteria>At completion Study CL0600021 , subject invited participate trial meet follow criterion : 1 . Completion 24month study , CL0600021 , regardless fully wean PN/I.V . support 2 . Signed date informed consent form ( ICF ) participate studyrelated procedure Study TEDC11001 perform</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Short bowel syndrome</keyword>
	<keyword>Parenteral nutrition</keyword>
	<keyword>PN</keyword>
	<keyword>HPN</keyword>
	<keyword>TPN</keyword>
	<keyword>SBS</keyword>
</DOC>